Is superiority to placebo the most appropriate measure of efficacy in trials of novel psychotropic medications? (2022)
Attributed to:
Investigating the Mechanisms of Placebo Anxiolysis
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.euroneuro.2022.06.003
PubMed Identifier: 35810615
Publication URI: http://europepmc.org/abstract/MED/35810615
Type: Journal Article/Review
Volume: 62
Parent Publication: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
ISSN: 0924-977X